Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z0HS
|
||||
| Former ID |
DIB009575
|
||||
| Drug Name |
Hu Dreg 55
|
||||
| Synonyms |
SMART Anti-L-Selectin
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Psoriasis [ICD9: 696; ICD10:L40] | Terminated | [1] | ||
| Company |
PDL BioPharma
|
||||
| Target and Pathway | |||||
| Target(s) | L-selectin | Target Info | [2] | ||
| KEGG Pathway | Cell adhesion molecules (CAMs) | ||||
| NetPath Pathway | IL9 Signaling Pathway | ||||
| IL2 Signaling Pathway | |||||
| Leptin Signaling Pathway | |||||
| Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | ||||
| Cell surface interactions at the vascular wall | |||||
| WikiPathways | Human Complement System | ||||
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | |||||
| Cell surface interactions at the vascular wall | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004232) | ||||
| REF 2 | Clinical pipeline report, company report or official report of glycomimetics. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.